Cargando…

Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018

BACKGROUND: Since the scale-up of routine viral load (VL) testing started in 2016, there is limited evidence on VL suppression rates under programmatic settings and groups at risk of non-suppression. We conducted a study to estimate VL non-suppression (> 1000 copies/ml) and its risk factors using...

Descripción completa

Detalles Bibliográficos
Autores principales: Mhlanga, Trudy Tholakele, Jacobs, Bart K. M., Decroo, Tom, Govere, Emma, Bara, Hilda, Chonzi, Prosper, Sithole, Ngwarai, Apollo, Tsitsi, Van Damme, Wim, Rusakaniko, Simbarashe, Lynen, Lutgarde, Makurumidze, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270749/
https://www.ncbi.nlm.nih.gov/pubmed/35810317
http://dx.doi.org/10.1186/s12981-022-00458-z
_version_ 1784744533321318400
author Mhlanga, Trudy Tholakele
Jacobs, Bart K. M.
Decroo, Tom
Govere, Emma
Bara, Hilda
Chonzi, Prosper
Sithole, Ngwarai
Apollo, Tsitsi
Van Damme, Wim
Rusakaniko, Simbarashe
Lynen, Lutgarde
Makurumidze, Richard
author_facet Mhlanga, Trudy Tholakele
Jacobs, Bart K. M.
Decroo, Tom
Govere, Emma
Bara, Hilda
Chonzi, Prosper
Sithole, Ngwarai
Apollo, Tsitsi
Van Damme, Wim
Rusakaniko, Simbarashe
Lynen, Lutgarde
Makurumidze, Richard
author_sort Mhlanga, Trudy Tholakele
collection PubMed
description BACKGROUND: Since the scale-up of routine viral load (VL) testing started in 2016, there is limited evidence on VL suppression rates under programmatic settings and groups at risk of non-suppression. We conducted a study to estimate VL non-suppression (> 1000 copies/ml) and its risk factors using "routine" and "repeat after enhanced adherence counselling (EAC)" VL results. METHODS: We conducted an analytic cross-sectional study using secondary VL testing data collected between 2014 and 2018 from a centrally located laboratory. We analysed data from routine tests and repeat tests after an individual received EAC. Our outcome was viral load non-suppression. Bivariable and multivariable logistic regression was performed to identify factors associated with having VL non-suppression for routine and repeat VL. RESULTS: We analysed 103,609 VL test results (101,725 routine and 1884 repeat test results) collected from the country’s ten provinces. Of the 101,725 routine and 1884 repeat VL tests, 13.8% and 52.9% were non-suppressed, respectively. Only one in seven (1:7) of the non-suppressed routine VL tests had a repeat test after EAC. For routine VL tests; males (vs females, adjusted odds ratio (aOR) = 1.19, [95% CI 1.14–1.24]) and adolescents (10–19 years) (vs adults (25–49 years), aOR = 3.11, [95% CI 2.9–3.31]) were more at risk of VL non-suppression. The patients who received care at the secondary level (vs primary, aOR = 1.21, [95% CI 1.17–1.26]) and tertiary level (vs primary, aOR = 1.63, [95% CI 1.44–1.85]) had a higher risk of VL non-suppression compared to the primary level. Those that started ART in 2014–2015 (vs < 2010, aOR = 0.83, [95% CI 0.79–0.88]) and from 2016 onwards (vs < 2010, aOR = 0.84, [95% CI 0.79–0.89]) had a lower risk of VL non-suppression. For repeat VL tests; young adults (20–24 years) (vs adults (25–49 years), (aOR) = 3.48, [95% CI 2.16 -5.83]), adolescents (10–19 years) (vs adults (25–49 years), aOR = 2.76, [95% CI 2.11–3.72]) and children (0–9 years) (vs adults (25–49 years), aOR = 1.51, [95% CI 1.03–2.22]) were at risk of VL non-suppression. CONCLUSION: Close to 90% suppression in routine VL shows that Zimbabwe is on track to reach the third UNAIDS target. Strategies to improve the identification of clients with high routine VL results for repeating testing after EAC and ART adherence in subpopulations (men, adolescents and young adolescents) at risk of viral non-suppression should be prioritised. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12981-022-00458-z.
format Online
Article
Text
id pubmed-9270749
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92707492022-07-10 Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018 Mhlanga, Trudy Tholakele Jacobs, Bart K. M. Decroo, Tom Govere, Emma Bara, Hilda Chonzi, Prosper Sithole, Ngwarai Apollo, Tsitsi Van Damme, Wim Rusakaniko, Simbarashe Lynen, Lutgarde Makurumidze, Richard AIDS Res Ther Research BACKGROUND: Since the scale-up of routine viral load (VL) testing started in 2016, there is limited evidence on VL suppression rates under programmatic settings and groups at risk of non-suppression. We conducted a study to estimate VL non-suppression (> 1000 copies/ml) and its risk factors using "routine" and "repeat after enhanced adherence counselling (EAC)" VL results. METHODS: We conducted an analytic cross-sectional study using secondary VL testing data collected between 2014 and 2018 from a centrally located laboratory. We analysed data from routine tests and repeat tests after an individual received EAC. Our outcome was viral load non-suppression. Bivariable and multivariable logistic regression was performed to identify factors associated with having VL non-suppression for routine and repeat VL. RESULTS: We analysed 103,609 VL test results (101,725 routine and 1884 repeat test results) collected from the country’s ten provinces. Of the 101,725 routine and 1884 repeat VL tests, 13.8% and 52.9% were non-suppressed, respectively. Only one in seven (1:7) of the non-suppressed routine VL tests had a repeat test after EAC. For routine VL tests; males (vs females, adjusted odds ratio (aOR) = 1.19, [95% CI 1.14–1.24]) and adolescents (10–19 years) (vs adults (25–49 years), aOR = 3.11, [95% CI 2.9–3.31]) were more at risk of VL non-suppression. The patients who received care at the secondary level (vs primary, aOR = 1.21, [95% CI 1.17–1.26]) and tertiary level (vs primary, aOR = 1.63, [95% CI 1.44–1.85]) had a higher risk of VL non-suppression compared to the primary level. Those that started ART in 2014–2015 (vs < 2010, aOR = 0.83, [95% CI 0.79–0.88]) and from 2016 onwards (vs < 2010, aOR = 0.84, [95% CI 0.79–0.89]) had a lower risk of VL non-suppression. For repeat VL tests; young adults (20–24 years) (vs adults (25–49 years), (aOR) = 3.48, [95% CI 2.16 -5.83]), adolescents (10–19 years) (vs adults (25–49 years), aOR = 2.76, [95% CI 2.11–3.72]) and children (0–9 years) (vs adults (25–49 years), aOR = 1.51, [95% CI 1.03–2.22]) were at risk of VL non-suppression. CONCLUSION: Close to 90% suppression in routine VL shows that Zimbabwe is on track to reach the third UNAIDS target. Strategies to improve the identification of clients with high routine VL results for repeating testing after EAC and ART adherence in subpopulations (men, adolescents and young adolescents) at risk of viral non-suppression should be prioritised. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12981-022-00458-z. BioMed Central 2022-07-09 /pmc/articles/PMC9270749/ /pubmed/35810317 http://dx.doi.org/10.1186/s12981-022-00458-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Mhlanga, Trudy Tholakele
Jacobs, Bart K. M.
Decroo, Tom
Govere, Emma
Bara, Hilda
Chonzi, Prosper
Sithole, Ngwarai
Apollo, Tsitsi
Van Damme, Wim
Rusakaniko, Simbarashe
Lynen, Lutgarde
Makurumidze, Richard
Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018
title Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018
title_full Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018
title_fullStr Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018
title_full_unstemmed Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018
title_short Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018
title_sort virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270749/
https://www.ncbi.nlm.nih.gov/pubmed/35810317
http://dx.doi.org/10.1186/s12981-022-00458-z
work_keys_str_mv AT mhlangatrudytholakele virologicaloutcomesandriskfactorsfornonsuppressionforroutineandrepeatviralloadtestingafterenhancedadherencecounsellingduringviralloadtestingscaleupinzimbabweanalyticcrosssectionalstudyusinglaboratorydatafrom2014to2018
AT jacobsbartkm virologicaloutcomesandriskfactorsfornonsuppressionforroutineandrepeatviralloadtestingafterenhancedadherencecounsellingduringviralloadtestingscaleupinzimbabweanalyticcrosssectionalstudyusinglaboratorydatafrom2014to2018
AT decrootom virologicaloutcomesandriskfactorsfornonsuppressionforroutineandrepeatviralloadtestingafterenhancedadherencecounsellingduringviralloadtestingscaleupinzimbabweanalyticcrosssectionalstudyusinglaboratorydatafrom2014to2018
AT govereemma virologicaloutcomesandriskfactorsfornonsuppressionforroutineandrepeatviralloadtestingafterenhancedadherencecounsellingduringviralloadtestingscaleupinzimbabweanalyticcrosssectionalstudyusinglaboratorydatafrom2014to2018
AT barahilda virologicaloutcomesandriskfactorsfornonsuppressionforroutineandrepeatviralloadtestingafterenhancedadherencecounsellingduringviralloadtestingscaleupinzimbabweanalyticcrosssectionalstudyusinglaboratorydatafrom2014to2018
AT chonziprosper virologicaloutcomesandriskfactorsfornonsuppressionforroutineandrepeatviralloadtestingafterenhancedadherencecounsellingduringviralloadtestingscaleupinzimbabweanalyticcrosssectionalstudyusinglaboratorydatafrom2014to2018
AT sitholengwarai virologicaloutcomesandriskfactorsfornonsuppressionforroutineandrepeatviralloadtestingafterenhancedadherencecounsellingduringviralloadtestingscaleupinzimbabweanalyticcrosssectionalstudyusinglaboratorydatafrom2014to2018
AT apollotsitsi virologicaloutcomesandriskfactorsfornonsuppressionforroutineandrepeatviralloadtestingafterenhancedadherencecounsellingduringviralloadtestingscaleupinzimbabweanalyticcrosssectionalstudyusinglaboratorydatafrom2014to2018
AT vandammewim virologicaloutcomesandriskfactorsfornonsuppressionforroutineandrepeatviralloadtestingafterenhancedadherencecounsellingduringviralloadtestingscaleupinzimbabweanalyticcrosssectionalstudyusinglaboratorydatafrom2014to2018
AT rusakanikosimbarashe virologicaloutcomesandriskfactorsfornonsuppressionforroutineandrepeatviralloadtestingafterenhancedadherencecounsellingduringviralloadtestingscaleupinzimbabweanalyticcrosssectionalstudyusinglaboratorydatafrom2014to2018
AT lynenlutgarde virologicaloutcomesandriskfactorsfornonsuppressionforroutineandrepeatviralloadtestingafterenhancedadherencecounsellingduringviralloadtestingscaleupinzimbabweanalyticcrosssectionalstudyusinglaboratorydatafrom2014to2018
AT makurumidzerichard virologicaloutcomesandriskfactorsfornonsuppressionforroutineandrepeatviralloadtestingafterenhancedadherencecounsellingduringviralloadtestingscaleupinzimbabweanalyticcrosssectionalstudyusinglaboratorydatafrom2014to2018